| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9311923 | Urology | 2005 | 6 Pages |
Abstract
Intravesical treatment with rAd-IFN facilitates high levels of IFN transgene exposure and may be a new approach to treating superficial bladder cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Robert J. Connor, Jennifer M. Anderson, Todd Machemer, Daniel C. Maneval, Heidrun Engler,